Target intelligence / Profile preview

Zinc finger protein 114 pseudogene

Molecular classification: Pseudogene, Other

Overview

Zinc finger protein 114 pseudogene (ENSG00000278720; LOC100132599) is classified as a pseudogene: a non-functional genomic sequence similar to the protein-coding zinc finger protein 114 gene. Pseudogenes do not produce functional proteins and are generally not considered direct therapeutic targets. No functional biological roles, disease associations, or drug interactions are attributed to this pseudogene. Its parent gene, ZNF114, is a DNA-binding protein involved in transcriptional regulation[1][3]. However, the pseudogene itself does not encode a protein product nor confer any known biological or pharmacological relevance.

Other names: LOC100132599ENSG00000278720zinc finger protein 114 pseudogene

Beyond the preview

Go deeper on Zinc finger protein 114 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 114 pseudogene.

Explore the full profile